Legal status · United States
Is Rapamycin legal in the United States?
Yes. Rapamycin is an approved medicine in the United States, classified as "FDA-approved (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Rapamycin in the United States at a glance
| Classification | FDA-approved (for its labeled use), prescription only |
|---|---|
| FDA approval status | FDA-approved (Rapamune); longevity use is off-label and investigational |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Rapamycin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Rapamycin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Rapamycin is
An FDA-approved mTOR inhibitor that extends lifespan in animals and is widely studied off-label at low, intermittent doses for longevity.
Rapamycin is an FDA-approved drug (Sirolimus) used to prevent transplant rejection and in certain conditions. It inhibits mTOR, a central growth and nutrient-sensing pathway, and is one of the most robust compounds for extending lifespan across animal species.
Mechanism: Inhibits the mTOR pathway, mimicking aspects of caloric restriction and enhancing autophagy and cellular maintenance.
Regulatory history: FDA-approved (Rapamune); longevity use is off-label and investigational
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Rapamycin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Rapamycin in other countries
United Kingdom
Approved medicineLicensed (for its labeled use), prescription only
Is Rapamycin legal in the United Kingdom?Australia
Approved medicineTGA-registered (for its labeled use), prescription only
Is Rapamycin legal in Australia?Canada
Approved medicineHealth Canada approved (for its labeled use), prescription only
Is Rapamycin legal in Canada?Frequently asked questions
Is Rapamycin legal in the United States?
Yes. Rapamycin is an approved medicine in the United States, classified as "FDA-approved (for its labeled use), prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Rapamycin in the United States?
Only with a prescription. Rapamycin is classified as "FDA-approved (for its labeled use), prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Rapamycin FDA approved?
Yes. FDA status: FDA-approved (Rapamune); longevity use is off-label and investigational. Current US classification: "FDA-approved (for its labeled use), prescription only". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Rapamycin live on its compound profile.
Rapamycin profileThis page is general information about the regulatory status of Rapamycin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.